Evolving Strategies to Improve Bone Health in Cancer Patients and Minimize the Burden of Skeletal-Related Events

On-Demand Webcast

This webcast is based on live proceedings from a satellite symposium that was conducted at the 46th ASHP Midyear Clinical Meeting and Exhibition


A Pharmacy Learning Network Educational Activity


Sponsored by North American Center for Continuing Medical Education, LLC

Presenters

Val Adams, PharmD, FCCP, BCOP
Associate Professor
Department of Pharmacy Practice and Science
University of Kentucky
Lexington, Kentucky

Rowena Schwartz, PharmD, BCOP
Director of Oncology Pharmacy
The Johns Hopkins Hospital
Baltimore, Maryland

Intended Learners

This activity is designed for health-system pharmacists.

Learning Objectives

After completing this activity, participants should be able to:

  • Describe the impact of skeletal-related events (SREs) in cancer patients on quality of life, clinical outcomes, and resource utilization
  • Outline the clinical profiles of available medications for improving bone health in patients with breast cancer, prostate cancer, and multiple myeloma
  • Summarize the current guidelines and evidence for appropriate use of bone-modifying agents as supportive therapy and as a primary cancer treatment

Activity Overview

This on-demand webcast is available with synchronized slides and audio.

To be eligible for documentation of credit, participants must complete the educational activity, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.

Release date: December 22, 2011
Expiration date: December 22, 2012
Estimated time to complete: 1.5 hours

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.

This educational activity is a knowledge-based activity.

There is no fee associated with this activity.

For questions regarding this educational activity, please call 609-371-1137.

Hardware/Software Requirements

All educational activities are accessible via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome or Safari. Windows Media Player or compatible alternative, sound card, and speakers are required for streamed audio. The latest version of the Adobe Flash Player is suggested (please download here) for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

Accreditation

In support of improving patient care, North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

CPE

This activity is approved for 1.5 contact hours (0.15 CEUs) of continuing pharmacy education (276-000-11-075-H01-P).

Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity accredited by NACCME may contact Assistant Director, Accreditation Services, NACCME, in writing at 300 Rike Drive, Suite A, Millstone Township, NJ 08535, or by e-mail at info@naccme.com. The Assistant Director, Accreditation Services will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Senior Director, Accreditation Services, NACCME, may be made for a second level of review.

Independent Clinical Reviewer: Casey Williams, PharmD, BCOP, Hematology/Oncology Clinical Coordinator and Residency Director, The University of Kansas Hospital, Kansas City, Kansas, Adjunct Clinical Assistant Professor, The University of Kansas School of Pharmacy, Lawrence, Kansas

Planning Committee

The planning committee comprises Val Adams, PharmD, FCCP, BCOP; Rowena Schwartz, PharmD, BCOP; Casey Williams, PharmD, BCOP; and Kristin Ciszeski, Mary Johnson, Michael Kearney, Nick Lombardi, Randy Robbin, and John Savage, NACCME.

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

Dr. Schwartz: Consultant—Amgen
Dr. Adams and Dr. Williams disclosed no relevant financial relationships with any commercial interests.

Ms. Ciszeski, Ms. Johnson, Mr. Kearney, Mr. Robbin, and Mr. Savage have disclosed no relevant financial relationships with any commercial interests.

Mr. Lombardi: Stock shareholder—Inspire Pharmaceuticals, Inc, Vertex Pharmaceuticals, Inc, ViroPharma, Inc

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty have disclosed that no off-label/unapproved uses of drugs and/or devices will be discussed.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2011 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.

Grant Support

Supported by an educational grant from Novartis Oncology.

  • Start Date: December 22, 2011
  • End Date: December 22, 2012
    • 1.50 CPE
  • Therapeutic Area:
    • Hospital medicine
    • Oncology